Can a Positive Allosteric Modulation of GABAergic Receptors Improve Motor Symptoms in Patients with Parkinson's Disease? The Potential Role of Zolpidem in the Treatment of Parkinson's Disease

At present, patients with advanced Parkinson's disease (PD) are unsatisfactorily controlled by currently used anti-Parkinsonian dopaminergic drugs. Various studies suggest that therapeutic strategies based on nondopaminergic drugs might be helpful in PD. Zolpidem, an imidazopyridine widely used...

Descripción completa

Detalles Bibliográficos
Autores principales: Daniele, Antonio, Panza, Francesco, Greco, Antonio, Logroscino, Giancarlo, Seripa, Davide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4886078/
https://www.ncbi.nlm.nih.gov/pubmed/27293955
http://dx.doi.org/10.1155/2016/2531812

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4886078/
https://www.ncbi.nlm.nih.gov/pubmed/27293955
http://dx.doi.org/10.1155/2016/2531812

Ejemplares similares